|
1
|
Carlson GW: Surgical anatomy of the neck.
Surg Clin North Am. 73:837–852. 1993.PubMed/NCBI
|
|
2
|
Alpay HC, Kalidag T, Keles E, Kaygusuz I,
Yalcin S and Kapusuz Z: The effects of fine-needle biopsy on
thyroid hormone levels. Otolaryngol Head Neck Surg. 136:942–945.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Welker MJ and Orlov D: Thyroid nodules. Am
Fam Physician. 67:559–566. 2003.PubMed/NCBI
|
|
4
|
Biersack HJ and Grunwald F: Thyroid
cancer. N Engl J Med. 345:1216–1217. 2001.
|
|
5
|
LeRoith D and Roberts CT: Insulin-like
growth factors. Ann N Y Acad Sci. 692:1–9. 1993. View Article : Google Scholar
|
|
6
|
Jones JI and Clemmons DR: Insulin-like
growth factors and their binding proteins: biological actions.
Endocr Rev. 16:3–34. 1995.PubMed/NCBI
|
|
7
|
Jorgensen JO, Blum WF, Moller N, Ranke MB
and Christiansen JS: Circadian patterns of serum insulin-like
growth factor (IGF) II and IGF binding protein 3 in growth
hormone-deficient patients and age-and sex-matched normal subjects.
Acta Endocrinol (Copenh). 123:257–262. 1990.
|
|
8
|
Laughlin GA, Barrett-Connor E, Criqui MH
and Kritz-Silverstein D: The prospective association of serum
insulin-like growth factor 1 (IGF-1) and IGF-binding protein-1
levels with all cause and cardiovascular disease mortality in older
adults: the Rancho Bernardo study. J Clin Endocrinol Metab.
89:114–120. 2004. View Article : Google Scholar
|
|
9
|
Renehan AG, Zwahlen M, Minder C, O’Dwyer
ST, Shalet SM and Egger M: Insulin-like growth factor (IGF-1), IGF
binding protein-3, and cancer risk: systematic review and meta-
regression analysis. Lancet. 363:1346–1353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Geusens PP and Boonen S: Osteoporosis and
the growth hormone-insulin-like growth factor axis. Horm Res.
58(Suppl 3): 49–55. 2002. View Article : Google Scholar
|
|
11
|
Pollak MN, Schernhammer ES and Hankinson
SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer.
4:505–518. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu X, Zhao H, Ado K, et al: Serum levels
of insulin growth factor (IGF-1) and IGF-binding protein predict
risk of second primary tumors in patients with head and neck
cancer. Clin Cancer Res. 10:3988–3995. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Endogenous Hormones and Breast Cancer
Collaborative Group. Key TJ, Appleby PN, Reeves GK and Roddam AW:
Insulin-like growth factor 1 (IGF1), IGF binding protein 3
(IGFBP3), and breast cancer risk: pooled individual data analysis
of 17 prospective studies. Lancet Oncol. 11:530–542. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mucci LA, Stark JR, Pollak MN, Li H, Kurth
T, Stampfer MJ and Ma J: Plasma levels of acid-labile subunit, free
insulin-like growth factor-I, and prostate cancer risk: a
prospective study. Cancer Epidemiol Biomarkers Prev. 19:484–491.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu H, Spitz MR, Mistry J, Gu J, Hong WK
and Wu X: Plasma levels of insulin-like growth factor-1 and lung
cancer risk: a case-control analysis. J Natl Cancer Inst.
91:151–156. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kimura T, van Keymeulen A, Golstein J,
Fusco A, Dumont JE and Roger PP: Regulation of thyroid cell
proliferation by TSH and other factors: a critical evaluation of in
vitro models. Endocr Rev. 22:631–656. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Juul A, Holm K, Kastrup KW, et al: Free
insulin-like growth factor I serum levels in 1430 healthy children
and adults, and its diagnostic value in patients suspected of
growth hormone deficiency. J Clin Endocrinol Metab. 82:2497–2502.
1997.PubMed/NCBI
|
|
18
|
Zimmermann-Belsing T, Juul A, Juul Holst J
and Feldt-Rasmussen U: The insulin-like growth axis in patients
with autoimmune thyrotoxicosis: effect of antithyroid drug
treatment. Growth Horm IGF Res. 14:235–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Desser TS and Kamaya A: Ultrasound of
thyroid nodules. Neuroimaging Clin N Am. 18:463–478. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frates MC, Benson CB, Charboneau JW, Cibas
ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB,
Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer
JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI and
Tessler FN; Society of Radiologists in Ultrasound. Management of
thyroid nodules detected at US: Society of Radiologists in
Ultrasound consensus conference statement. Radiology. 237:794–800.
2005. View Article : Google Scholar
|
|
21
|
Cappelli C, Pirola I, Cumetti D, et al: Is
the anteroposterior and transverse diameter ratio of nonpalpable
thyroid nodules a sonographic criteria for recommending fine-needle
aspiration cytology? Clin Endocrinol (Oxf). 63:689–693. 2005.
View Article : Google Scholar
|
|
22
|
Papini E, Guglielmi R, Bianchini A, et al:
Risk of malignancy in nonpalpable thyroid nodules: predictive value
of ultrasound and color-Doppler features. J Clin Endocrinol Metab.
87:1941–1946. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sriram U and Patacsil LM: Thyroid nodules.
Dis Mon. 50:486–526. 2004. View Article : Google Scholar
|
|
24
|
LeRoith D and Roberts CT: The insulin-like
growth factor system and cancer. Cancer Lett. 95:127–137. 2003.
View Article : Google Scholar
|
|
25
|
Shevah O and Laron Z: Patients with
congenital deficiency of IGF-1 seem protected from the development
of malignancies: a preliminary report. Growth Horm IGF Res.
17:54–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tita P, Ambrosio MR, Scollo C, et al: High
prevalence of differentiated thyroid carcinoma in acromegaly. Clin
Endocrinol (Oxf). 63:161–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eszlinger M, Krohn K, Kratzsch J, Voigt C
and Paschke R: Growth factor expression in cold and hot thyroid
nodules. Thyroid. 11:125–135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Völzke H, Friedrich N, Schipf S, et al:
Association between serum insulin-like growth factor-1 levels and
thyroid disorders in a population-based study. J Clin Endocrinol
Metab. 92:4039–4045. 2007.PubMed/NCBI
|
|
29
|
Leifke E, Gorenoi V, Wichers C, von Zur
Mühlen A, von Büren E and Brabant G: Age-related changes of serum
sex hormones, insulin-like growth factor-1 and sex-hormone binding
globulin levels in men: cross-sectional data from a healthy male
cohort. Clin Endocrinol (Oxf). 53:689–695. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsiao PJ and Tsai JH: Increased
insulin-like growth factor-1 receptors in thyroid tissues of
Graves’ disease. J Formos Med Assoc. 93:925–32. 1994.
|
|
31
|
Surmacz E and Bartucci M: Role of estrogen
receptor alpha in modulating IGF-I receptor signaling and function
in breast cancer. J Exp Clin Cancer Res. 23:385–394.
2004.PubMed/NCBI
|
|
32
|
Ingbar SH, Tramontano D and
Amebesi-Impiombato S: Observations on the regulation of thyroid
cell growth. Horm Metab Res Suppl. 17:43–51. 1987.PubMed/NCBI
|
|
33
|
Ciampolillo A, de Tullio C and Giorgino F:
The IGF-1/IGF-1 receptor pathway: implications in the
pathophysiology of thyroid cancer. Curr Med Chem. 12:2881–2891.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barnes CJ, Ohshiro K, Rayala SK, El-Naggar
AK and Kumar R: Insulin-like growth factor receptor as a
therapeutic target in head and neck cancer. Clin Cancer Res.
13:4291–4299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clemmons DR: Clinical utility of
measurements of insulin-like growth factor 1. Nat Clin Pract
Endocrinol Metab. 2:436–446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Clayton PE and Hall CM: Insulin-like
growth factor I levels in healthy children. Horm Res. 62(Suppl 1):
2–7. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maes M, Underwood LE and Ketelslegers JM:
Low serum somatomedin-C in insulin-dependent diabetes: evidence for
a postreceptor mechanism. Endocrinology. 118:377–382. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kirschner BS and Sutton MM: Somatomedin-C
levels in growth-impaired children and adolescents with chronic
inflammatory bowel disease. Gastroenterology. 91:830–836.
1986.PubMed/NCBI
|
|
39
|
Wu JC, Daughaday WH, Lee SD, et al:
Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic
liver diseases and hepatocellular carcinoma with or without
hypoglycemia. J Lab Clin Med. 112:589–594. 1988.PubMed/NCBI
|
|
40
|
Foppiani L, Sulli A, Prete C, et al:
Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the
study of the hypothalamic-pituitary-adrenal axis in premenopausal
rheumatoid arthritis patients. Ann N Y Acad Sci. 876:83–87. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hochberg Z: Mechanisms of steroid
impairment of growth. Horm Res. 58(Suppl 1): 33–38. 2002.
View Article : Google Scholar : PubMed/NCBI
|
